News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
7,812 Results
Type
Article (81)
Press Release (7731)
Section
Business (4814)
Career Advice (2)
Deals (584)
Drug Development (455)
FDA (52)
Job Trends (164)
News (5483)
Policy (116)
Tag
Academia (5)
Allergies (3)
Alliances (149)
ALS (2)
Alzheimer's disease (25)
Antibody-drug conjugate (ADC) (1)
Approvals (55)
Artificial intelligence (1)
Best Places to Work (153)
Biosimilars (2)
Bladder cancer (3)
Breast cancer (4)
Cancer (40)
Cardiovascular disease (3)
Career advice (2)
CAR-T (3)
Cell therapy (12)
Clinical research (423)
Collaboration (6)
Compensation (5)
COVID-19 (9)
CRISPR (1)
C-suite (4)
Cystic fibrosis (1)
Data (58)
Depression (1)
Diabetes (5)
Diagnostics (76)
Digital health (1)
Drug discovery (1)
Earnings (5254)
Events (549)
Executive appointments (3)
FDA (134)
Frontotemporal dementia (1)
Funding (3)
Gene editing (1)
GLP-1 (9)
Government (10)
Guidances (71)
Healthcare (248)
HIV (1)
Immunology and inflammation (1)
Indications (2)
Infectious disease (9)
Inflammatory bowel disease (2)
Intellectual property (2)
IPO (502)
Job creations (13)
Job search strategy (2)
Labor market (1)
Legal (16)
Lung cancer (5)
Lymphoma (10)
Manufacturing (7)
MASH (6)
Medical device (261)
Medtech (262)
Mergers & acquisitions (89)
Metabolic disorders (15)
Multiple sclerosis (4)
NASH (1)
Neurodegenerative disease (2)
Neuropsychiatric disorders (2)
Neuroscience (39)
NextGen: Class of 2026 (38)
Non-profit (12)
Obesity (4)
Pancreatic cancer (2)
Parkinson's disease (3)
Patents (2)
Patient recruitment (2)
Peanut (1)
People (135)
Pharmacy benefit managers (1)
Phase 1 (119)
Phase 2 (190)
Phase 3 (155)
Pipeline (303)
Postmarket research (4)
Preclinical (41)
Prostate cancer (3)
Radiopharmaceuticals (2)
Rare diseases (7)
Real estate (20)
Regulatory (106)
Reports (2)
Research institute (9)
Schizophrenia (1)
Sickle cell disease (2)
Startups (6)
Vaccines (3)
Women's health (1)
Date
Last 7 days (13)
Last 30 days (61)
Last 365 days (551)
2026 (150)
2025 (563)
2024 (662)
2023 (780)
2022 (855)
2021 (844)
2020 (741)
2019 (512)
2018 (394)
2017 (302)
2016 (128)
2015 (202)
2014 (169)
2013 (94)
2012 (170)
2011 (159)
2010 (221)
Location
Africa (4)
Alabama (2)
Arizona (7)
Arkansas (2)
Asia (355)
Australia (22)
California (213)
Canada (71)
China (14)
Colorado (12)
Connecticut (6)
Delaware (3)
Europe (1123)
Florida (24)
Georgia (4)
Idaho (1)
Illinois (34)
India (1)
Indiana (15)
Japan (3)
Kentucky (2)
Louisiana (4)
Maine (2)
Maryland (27)
Massachusetts (159)
Michigan (4)
Minnesota (20)
Missouri (4)
Nevada (1)
New Hampshire (3)
New Jersey (59)
New York (57)
North Carolina (23)
Northern California (114)
Ohio (9)
Pennsylvania (57)
South America (11)
Southern California (83)
Tennessee (12)
Texas (57)
United States (841)
Utah (15)
Virginia (2)
Washington State (20)
7,812 Results for "479".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arcutis Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 26, 2026
·
12 min read
Press Releases
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
March 30, 2026
·
12 min read
Press Releases
GenSight Biologics Reports Estimated Full-Year Consolidated Financial Results for 2025
March 27, 2026
·
17 min read
Press Releases
Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 13, 2026
·
9 min read
Press Releases
IO Biotech Provides Corporate Update - January 30, 2026
February 1, 2026
·
2 min read
Press Releases
Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
March 30, 2026
·
13 min read
Press Releases
Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen
December 10, 2025
·
5 min read
BioMidwest
Revolo Biotherapeutics Awarded Patent for ‘1104 in Acute Treatment of Relapsing Remitting Conditions
Revolo Biotherapeutics announced that the U.S. Patent and Trademark Office issued US Patent No. 11,479,585 on October 25, 2022, which covers IRL201104 and related peptides in methods related to the acute treatment of relapsing remitting conditions.
November 2, 2022
·
2 min read
Press Releases
Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray
March 16, 2026
·
4 min read
Press Releases
Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray
March 20, 2026
·
4 min read
Previous
2 of 782
Next
